Key result
Beta-blockers are underutilized in older CAD or prior MI patients, reaching only ~27% uptake.
Why the study?
This study investigated the prevalence of beta-blocker use in older persons with prior MI or CAD without contraindications to beta-blockers in an academic, hospital-based geriatrics practice.
Observational (n=233)
No
This study highlights a marked underutilization of beta-blockers for secondary prevention in older patients with CAD or prior MI in an academic geriatrics practice setting.
Answers are grounded in this paper and cite their sources.
Marked underutilization of beta-blockers in older CAD/MI patients; leaves open whether targeted interventions improve secondary prevention rates.
Objective To investigate the prevalence of beta-blocker use in older persons with prior myocardial infarction (MI) or coronary artery disease (CAD) without contraindications to beta-blockers in an academic hospital-based geriatrics practice. Design A retrospective analysis of charts from all older patients seen during January 1996 through March 1997 at an academic, hospital-based geriatrics practice was performed to investigate the prevalence of beta-blocker use in older patients with prior MI or CAD without contraindications to beta blockers. Setting An academic, hospital-based, primary care geriatrics practice staffed by fellows in a geriatrics training program and full-time faculty geriatricians. Patients One hundred thirty-nine women and 84 men, mean age 82 +/- 8 years (range 67 to 96), were included in the study. Measurements and main results Of 233 patients with CAD, 53 patients (23%) were receiving beta-blockers. Of 180 patients with CAD not receiving beta-blockers, 34 patients (19%) had contraindications to beta-blockers. Of 199 patients with CAD without contraindications to beta-blockers, 53 patients (27%) were receiving beta blockers. Of 162 patients with prior MI, 38 patients (23%) were receiving beta-blockers. Of 124 patients with prior MI not receiving beta-blockers, 19 patients (15%) had contraindications to beta-blockers. Of 143 patients with prior MI without contraindications to beta-blockers, 38 patients (27%) were receiving beta-blockers. Conclusions There is marked underutilization of beta-blockers in treating older patients with prior MI or CAD in an academic, hospital-based geriatrics practice.
No takes yet. Share an insight, caveat, or question.
Mendelson et al. (1997) conducted an observational in Prior myocardial infarction or coronary artery disease (n=233). Beta-blocker therapy was evaluated on Prevalence of beta-blocker use in older patients with CAD or prior MI without contraindications. Beta-blocker therapy was utilized in only 27% of older patients with CAD or prior MI who had no contraindications to beta-blockers.
Synapse has enriched 10 related papers. Consider them for comparative context: